Coya Therapeutics (COYA)
Develops Treg-focused therapies for neurodegenerative and immune-mediated diseases.
$5.29
vs last close+0.34 (+6.87%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
estimated · in 50 days
EPS estimate
−$0.35
Revenue estimate
$110.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.18−$0.44−$0.36−$0.10−$0.34−$0.32−$0.28Pending
Estimate−$0.26−$0.44−$0.22$0.02−$0.27−$0.39−$0.35−$0.35
Surprise+30.8%0.0%−63.6%−600.0%−24.8%+17.9%+19.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$2.0K$257.9K$163.6K$3.6M$4.0M$300.0K$221.9KPending
Estimate$100.0K$2.6M$783.3K$1.9M$2.2M$150.0K$130.0K$110.0K
Surprise−98.0%−90.2%−79.1%+85.1%+78.0%+100.0%+70.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.35 | — | — |
| Sep 2028 | $0.74 | — | — |
| Jun 2028 | −$0.29 | — | — |
| Mar 2028 | −$0.31 | — | — |
| Dec 2027 | −$0.42 | — | — |
| Sep 2027 | −$0.32 | — | — |
| Jun 2027 | −$0.34 | — | — |
| Mar 2027 | −$0.41 | — | — |
| Dec 2026 | −$0.37 | — | — |
| Nov 2026 | −$0.35 | — | — |
| Aug 2026 | −$0.35 | −$0.28 | +19.0% |
| May 2026 | −$0.39 | −$0.32 | +17.9% |
| Mar 2026 | −$0.27 | −$0.34 | −24.8% |
| Nov 2025 | $0.02 | −$0.10 | −600.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Sep 2022 | |||
| Dec 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.35 | — | — | $367.1K | — | — | — |
| Sep 2028 | $0.74 | — | — | $25.0M | — | — | — |
| Jun 2028 | −$0.29 | — | — | $321.3K | — | — | — |
| Mar 2028 | −$0.31 | — | — | $310.4K | — | — | — |
| Dec 2027 | −$0.42 | — | — | $150.0K | — | — | — |
| Sep 2027 | −$0.32 | — | — | $150.0K | — | — | — |
| Jun 2027 | −$0.34 | — | — | $3.4M | — | — | — |
| Mar 2027 | −$0.41 | — | — | $100.0K | — | — | — |
| Dec 2026 | −$0.37 | — | — | $660.0K | — | — | — |
| Nov 11, 2026 | −$0.35 | — | — | $110.0K | — | — | — |
| Aug 11, 2026 | −$0.35 | −$0.28 | +19.0% | $130.0K | $221.9K | +70.7% | +3.5% |
| May 12, 2026 | −$0.39 | −$0.32 | +17.9% | $150.0K | $300.0K | +100.0% | +2.6% |
| Mar 16, 2026 | −$0.27 | −$0.34 | −24.8% | $2.2M | $4.0M | +78.0% | −0.7% |
| Nov 12, 2025 | $0.02 | −$0.10 | −600.0% | $1.9M | $3.6M | +85.1% | +1.3% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 18, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 19, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 29, 2023 | |||||||
| Sep 30, 2022 | |||||||
| Dec 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 |